MCT-PATHWAY
Participant type
Overview
This study is no longer looking for new participants but is still ongoing.
The MCT Pathway programme ran from 2014 to 2021. Its goal was to improve the health and quality of life of heart disease patients and to reduce the risk of further cardiac events through cardiac rehabilitation services.
Summary
What is the study about?
In the UK, approximately 69,000 patients attend cardiac rehabilitation services each year. Around 37% of these patients experience significant anxiety and/or depressive symptoms, which can reduce their quality of life and increase the risk of death, further cardiac events, and healthcare use.
Current drug and talking based treatments only have small effects on decreasing anxiety and low mood and on improving quality of life, more effective treatments for depression and anxiety are needed in cardiac rehabilitation services.
Metacognitive Therapy was developed by Professor Adrian Wells. It directly reduces worry, rumination and unhelpful thinking styles and modifies the specific beliefs behind them. It is a psychological treatment that helps people to manage worries and low mood through reducing unhelpful styles of thinking and has been shown to alleviate depression and anxiety in mental health settings.
Extensive evidence shows that a particular style of thinking dominated by rumination (dwelling on the past) and worry (concerns about the future) maintains emotional distress. Metacognitive therapy helps people to discover new and more helpful ways to react to negative or distressing thoughts, so they are less likely to dwell on them, resulting in a positive effect on anxiety and mood.
What are you trying to find out?
- Group Based MCT PATHWAY: A single-blind randomised controlled trial with a four month and 12 month follow up comparing Group-Metacognitive Therapy plus usual cardiac rehabilitation (intervention group) with usual cardiac rehabilitation alone (control group) with 332 patients
- Home Based Metacognitive Therapy: A single-blind randomised controlled trial comparing Home-Based Metacognitive Therapy plus usual cardiac rehabilitation (intervention group) with usual cardiac rehabilitation alone (control group) with 242 patients
What does taking part involve?
As part of the PATHWAY trial, we delivered metacognitive therapy in a group of 3-10 patients. Patients received six sessions that lasted 60 minutes. Sessions were delivered by a trained health professional from cardiac rehabilitation services, this includes nurses, physiotherapists, and occupational therapists.
How can I find out more?
You can find out more information about this study by visiting the ADePT research unit's project page here.
This study is no longer looking for new participants but is still ongoing.
However, if you have questions for the research team, click the button below to email the research team:
Collaborators
As a service user, relative or carer using our services, sometimes you may need to turn to someone for help, advice, and support.
Find resources for carers and service users Contact the Trust